Key visual

Join our Scientific Biomarker Sessions 

The digital sessions will focus on the use of biomarkers and how they can be used in the clinic and improve patient care

Enhanced Liver Fibrosis (ELF)

ELF Test Blood draw

NAFLD impacts 25% of the global population. Because of the increasing global burden of non-alcoholic fatty liver disease, lack of appropriate non-invasive testing options is a major concern. The performance of the ELF Test for assessing risk of progression to cirrhosis and Liver Related Events has been well-established in scientific literature, and ease of testing and interpretation support routine clinical use. Register for the Enhanced Liver Fibrosis Session and hear how the ELF score can improve patient pathway and ease the workload at the gastro-enterology departments.

Target audience: Laboratory professionals, Hepatologists and Hospital Administration
Speakers: more info to come
Time: tbd, 14.00 - 15.00 CET


Squamous Cell Carcinoma (SCC)

cVRT image of lesion

CT-image of lesion. Pancreatic squamous cell carcinoma. 

In vitro diagnostic testing for Squamous Cell Carcinoma using the SCC assay can help clinicians monitor disease progression during the course of disease and treatment in squamous cell carcinoma in lung, cervical, and head and neck cancer patients. Join the meeting and learn more about Squamous Cell Carcinoma serial testing from a simple blood sample.

Target audience: Laboratory professionals, Oncologists and Hospital Administration
Speakers: more info to come
Time: tbd, 14.00 - 15.00 CET


Vitamin B-12 Deficiency

Biomarkers

Vitamin B12 (cobalamin) plays an important role in DNA synthesis and neurologic function. But is measuring Total Vitamin B12 the best choice? Vitamin B12 deficiency can lead to a wide spectrum of hematologic and neuropsychiatric disorders which can be reversed by early diagnosis and prompt treatment. Join the meeting and listen to experts talk about diagnosing Vitamin B-12 deficiencies by making use of Active B12 (holotranscobalamin) measurement.

Target audience: Laboratory professionals, Hepatologists and Hospital Administration
Speakers: more info to come
Time: tbd, 14.00 - 15.00 CET


HER2 Positive Breast Cancer

Reducing fear and anxiety associated with breast-cancer screening

Measurement of circulating levels of the HER-2/neu oncoprotein in the follow-up and monitoring of patients with metastatic breast cancer yields important information about response to therapy and may help physicians´ developing and modifying patient treatment regimens. Join the meeting and hear about the most recent findings.

Target audience: Laboratory professionals, Oncologists and Hospital Administration
Speakers: more info to come
Time: tbd, 14.00 - 15.00 CET